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Unusual electrocardiographic presentation of conduction 
disturbances from acute use of chloroquine: rare case report
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Abstract
23-year-old man presented with Stokes-Adams attacks due to sinus node dysfunction. He was being treated for malaria 
with chloroquine for the last two days. Temporary pacemaker was implanted. Subsequently he developed all spectrum 
of atrioventricular block following recovery of sinus node dysfunction which also recovered on the fifteenth day and was 
discharged. Cardiac damage, such as cardiomyopathy and conduction system disturbances, is regarded as uncommon 
consequences of acute chloroquines’s toxicity. Here we present a case in which chloroquine used as acute therapy 
for malaria resulted in conduction disorder beginning from sinus node dysfunction to Mobitz I atrioventricular block to 
complete heart block with recovery to normal sinus rhythm in single patient.
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Introduction
Chloroquine as a derivative of 4-aminoquinoline has been 
widely used as an antimalarial agent and for rheumato-
logical treatment, but potential severe side effects require 
careful follow-up. Cardiac damage is not a common conse-
quence. Owing to its narrow therapeutic index the drug is 
relatively toxic, especially in the case of an overdose, an 
acute intoxication or chronic uses for rheumatological dis-
orders. Conduction disorders in usual doses are extremely 
rare and such presentation in single patient is even rarer.
Case report
We report the case of a 23-year-old man with P. vivax ma-
laria, diagnosed three days ago. Subsequently treatment 
with chloroquine in usual dose: 600 mg. was initiated and 
then 300 mg 6, 24 and 48 hours after the first dose. He was 
admitted with syncope. No other previous cardiovascular 
symptoms were reported. There was no family history of 
cardiac disease. His physical examination was normal on 
admission except for the pulse rate of 37 bpm. The elec-
trocardiogram showed sinus node dysfunction with left 
bundle-branch block QRS morphology (Fig. 1). Temporary 
pacemaker implantation was done under aseptic condi-
tion after proper consent. Routine blood investigations, 
electrolytes (calcium, phosphorus, magnesium, sodium, 
and potassium) and cardiac biomarkers (myoglobin, CPK- 
-MB and troponins) were normal. Others parameters such 
as serum bilirubin, AST and ALT, blood urea and serum 
creatinine were within normal range. The echocardiogram 
revealed normal cardiac function and cavity dimensions 
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and thus congenital heart diseases were ruled out. Holter 
monitoring was also done to rule out any tachyarrhythmias 
in form of NSVT or VT. Sinus node dysfunction recovered 
on fourth day. He subsequently developed Mobitz type 
I atrioventricular block (Fig. 2) and complete heart block on 
the seventh day (Fig. 3) which finally recovered to normal 
sinus rhythm on the fifteenth day. Coronary angiography 
was normal. Patient was discharged in stable condition.
Discussion
Chloroquine is an antimalarial drug of 4-aminoquinolines 
group. Chloroquine is the drug of choice for clinical cure 
and suppressive prophylaxis of all types of malaria, except 
that caused by resistant P-falciparum. Chloroquine exerts 
its toxicity by quinidine-like mechanisms. It is a profound 
negative inotrope and a vasodilator. It also slows intraven-
tricular conduction. Oral chloroquine is rapidly and almost 
completely absorbed, resulting in transiently high blood 
concentrations early in the distribution phase that are 
potentially cardiotoxic [1]. Chloroquine, like amiodarone 
(class III anti-arrhythmic) is inhibitor of phospholipase 
activity and induces cytoplasmic inclusion body formation. 
Chloroquine is accumulated in lysosomes, directly inhibiting 
enzymatic activity, increasing lysosomal pH and causing 
protein inactivity [2, 3]. Because of its properties, it may 
cause arrhythmias [2, 4]. Major arrhythmias basically 
caused by chronic use of chloroquine have been attributed 
to significant reduction in the cardiac ascent rate, increa-
ses in the potential length duration, and Purkinje fibbers 
refractory period [3, 5]. The usual electrocardiographic 
alteration is fascicular block, which can lead to advanced 
types of atrioventricular block causing syncope [6]. Acute 
rhythm disturbances with usual dose is extremely rare. The 
diagnosis of chloroquine cardio toxicity is determined by 
endomyocardial biopsy. Holter study ruling out any tach-
yarrhythmia’s also negated any drug induced myocarditis. 
Also his cardiac biomarkers were negative and LV functions 
were normal, also supported our case. Although histologic 
studies were not performed in our patient, the clinical evi-
dence of toxicity, absence of underlying heart disease, fairly 
young age of the patient and the duration of use pointed to 
chloroquine toxicity. Sinus node dysfunction alone in acute 
use of chloroquine is very rare though has been reported 
as chloroquine-induced cardiomyopathy involving the heart 
conduction system [7]. Our case is unique as sinus node 
dysfunction without cardiomyopathy in acute setting is rare. 
Also Mobitz-I AV block progressing to complete heart block 
and recovering to normal sinus rhythm is too unusual. As 
normal sinus rhythm was restored, patient was discharged 
without pacemaker.
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Figure 1. Sinus node dysfunction with left bundle-branch block 
QRS morphology 
Figure 2. Complete heart block with ventricular escape of 22/min
Figure 3. Mobitz type I atrioventricular block
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Streszczenie
Mężczyzna w wieku 23 lat zgłosił się do lekarza z powodu napadów Morgagniego-Adamsa-Stokesa będących następ-
stwem dysfunkcji węzła zatokowego. Przez ostatnie 2 dni stosował chlorochinę w ramach leczenia przeciwmalarycz-
nego. Tymczasowo wszczepiono mu stymulator serca. Po ustąpieniu zaburzeń węzła zatokowego u chorego rozwinął 
się pełny blok przedsionkowo-komorowy, który również ustąpił po 15 dniach i chorego wypisano do domu. Uszkodzenie 
serca w postaci kardiomiopatii lub zaburzeń przewodzenia jest rzadkim następstwem ostrego toksycznego działania 
chlorochiny. W artykule przedstawiono przypadek pacjenta, u którego po zastosowaniu chlorochiny w leczeniu ostrego 
napadu malarii wystąpiło całe spektrum zaburzeń przewodzenia — od dysfunkcji węzła zatokowego, przez blok przed-
sionkowo-komorowy typu Mobitz I, do całkowitego bloku przedsionkowo komorowego — zakończonych przywróceniem 
prawidłowego rytmu zatokowego.
Słowa kluczowe: chlorochina, całkowity blok serca, malaria, blok przedsionkowo-komorowy typu Mobitz I, dysfunkcja 
węzła zatokowego
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